S&P 500   5,036.95 (+1.40%)
DOW   38,433.44 (+1.18%)
QQQ   420.42 (+1.39%)
AAPL   166.98 (+1.20%)
MSFT   401.52 (+0.60%)
META   486.72 (+1.17%)
GOOGL   157.32 (+2.10%)
AMZN   177.56 (+1.68%)
TSLA   142.02 (-3.42%)
NVDA   797.62 (+4.67%)
AMD   149.32 (+1.83%)
NIO   4.03 (+6.05%)
BABA   70.74 (+2.42%)
T   16.35 (-0.97%)
F   12.89 (+6.18%)
MU   109.43 (+2.49%)
GE   151.40 (+2.26%)
CGC   8.01 (+1.01%)
DIS   113.43 (+0.73%)
AMC   3.39 (+7.28%)
PFE   26.48 (+1.85%)
PYPL   63.52 (+1.94%)
XOM   121.42 (+1.28%)
S&P 500   5,036.95 (+1.40%)
DOW   38,433.44 (+1.18%)
QQQ   420.42 (+1.39%)
AAPL   166.98 (+1.20%)
MSFT   401.52 (+0.60%)
META   486.72 (+1.17%)
GOOGL   157.32 (+2.10%)
AMZN   177.56 (+1.68%)
TSLA   142.02 (-3.42%)
NVDA   797.62 (+4.67%)
AMD   149.32 (+1.83%)
NIO   4.03 (+6.05%)
BABA   70.74 (+2.42%)
T   16.35 (-0.97%)
F   12.89 (+6.18%)
MU   109.43 (+2.49%)
GE   151.40 (+2.26%)
CGC   8.01 (+1.01%)
DIS   113.43 (+0.73%)
AMC   3.39 (+7.28%)
PFE   26.48 (+1.85%)
PYPL   63.52 (+1.94%)
XOM   121.42 (+1.28%)
S&P 500   5,036.95 (+1.40%)
DOW   38,433.44 (+1.18%)
QQQ   420.42 (+1.39%)
AAPL   166.98 (+1.20%)
MSFT   401.52 (+0.60%)
META   486.72 (+1.17%)
GOOGL   157.32 (+2.10%)
AMZN   177.56 (+1.68%)
TSLA   142.02 (-3.42%)
NVDA   797.62 (+4.67%)
AMD   149.32 (+1.83%)
NIO   4.03 (+6.05%)
BABA   70.74 (+2.42%)
T   16.35 (-0.97%)
F   12.89 (+6.18%)
MU   109.43 (+2.49%)
GE   151.40 (+2.26%)
CGC   8.01 (+1.01%)
DIS   113.43 (+0.73%)
AMC   3.39 (+7.28%)
PFE   26.48 (+1.85%)
PYPL   63.52 (+1.94%)
XOM   121.42 (+1.28%)
S&P 500   5,036.95 (+1.40%)
DOW   38,433.44 (+1.18%)
QQQ   420.42 (+1.39%)
AAPL   166.98 (+1.20%)
MSFT   401.52 (+0.60%)
META   486.72 (+1.17%)
GOOGL   157.32 (+2.10%)
AMZN   177.56 (+1.68%)
TSLA   142.02 (-3.42%)
NVDA   797.62 (+4.67%)
AMD   149.32 (+1.83%)
NIO   4.03 (+6.05%)
BABA   70.74 (+2.42%)
T   16.35 (-0.97%)
F   12.89 (+6.18%)
MU   109.43 (+2.49%)
GE   151.40 (+2.26%)
CGC   8.01 (+1.01%)
DIS   113.43 (+0.73%)
AMC   3.39 (+7.28%)
PFE   26.48 (+1.85%)
PYPL   63.52 (+1.94%)
XOM   121.42 (+1.28%)
NYSE:AVTR

Avantor (AVTR) Stock Price, News & Analysis

$24.50
+0.40 (+1.66%)
(As of 02:16 PM ET)
Today's Range
$24.05
$24.51
50-Day Range
$22.13
$26.07
52-Week Range
$16.63
$26.16
Volume
2.42 million shs
Average Volume
5.65 million shs
Market Capitalization
$16.62 billion
P/E Ratio
51.04
Dividend Yield
N/A
Price Target
$26.71

Avantor MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
10.0% Upside
$26.71 Price Target
Short Interest
Bearish
4.32% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.27
Upright™ Environmental Score
News Sentiment
0.71mentions of Avantor in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$151,911 Sold Last Quarter
Proj. Earnings Growth
22.77%
From $1.01 to $1.24 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.28 out of 5 stars

Medical Sector

68th out of 907 stocks

Analytical Instruments Industry

2nd out of 26 stocks

AVTR stock logo

About Avantor Stock (NYSE:AVTR)

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

AVTR Stock Price History

AVTR Stock News Headlines

Avantor (NYSE:AVTR) PT Raised to $25.00
BUY ALERT: Billionaires piling into this asset class
Legendary investor Warren Buffett has poured over $500 million into gold! It's a BIG move by one of the world's most cautious investors.
Avantor (AVTR) Scheduled to Post Quarterly Earnings on Friday
Bank of America Securities Keeps Their Buy Rating on Avantor (AVTR)
RBC Capital Keeps Their Buy Rating on Avantor (AVTR)
BUY ALERT: Billionaires piling into this asset class
Legendary investor Warren Buffett has poured over $500 million into gold! It's a BIG move by one of the world's most cautious investors.
9 Analysts Assess Avantor: What You Need To Know
AVTR Mar 2024 27.500 put
AVTR Mar 2024 26.000 call
AVTR Mar 2024 24.500 put
AVTR Mar 2024 25.000 call
AVTR Mar 2024 29.000 put
New Strong Sell Stocks for February 20th
See More Headlines
Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/14/2024
Today
4/22/2024
Next Earnings (Confirmed)
4/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Fax
N/A
Employees
14,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$26.71
High Stock Price Target
$30.00
Low Stock Price Target
$22.00
Potential Upside/Downside
+10.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
16 Analysts

Profitability

Net Income
$321.10 million
Pretax Margin
5.89%

Debt

Sales & Book Value

Annual Sales
$6.97 billion
Cash Flow
$1.68 per share
Book Value
$7.77 per share

Miscellaneous

Free Float
669,463,000
Market Cap
$16.37 billion
Optionable
Optionable
Beta
1.37
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

AVTR Stock Analysis - Frequently Asked Questions

Should I buy or sell Avantor stock right now?

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 4 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AVTR shares.
View AVTR analyst ratings
or view top-rated stocks.

What is Avantor's stock price target for 2024?

16 equities research analysts have issued 1-year target prices for Avantor's shares. Their AVTR share price targets range from $22.00 to $30.00. On average, they predict the company's share price to reach $26.71 in the next twelve months. This suggests a possible upside of 10.0% from the stock's current price.
View analysts price targets for AVTR
or view top-rated stocks among Wall Street analysts.

How have AVTR shares performed in 2024?

Avantor's stock was trading at $22.83 at the beginning of the year. Since then, AVTR shares have increased by 6.4% and is now trading at $24.29.
View the best growth stocks for 2024 here
.

Are investors shorting Avantor?

Avantor saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 29,290,000 shares, an increase of 6.6% from the March 15th total of 27,470,000 shares. Based on an average trading volume of 5,900,000 shares, the days-to-cover ratio is currently 5.0 days.
View Avantor's Short Interest
.

When is Avantor's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, April 26th 2024.
View our AVTR earnings forecast
.

How can I listen to Avantor's earnings call?

Avantor will be holding an earnings conference call on Friday, April 26th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Avantor's earnings last quarter?

Avantor, Inc. (NYSE:AVTR) issued its quarterly earnings data on Wednesday, February, 14th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.03. The business had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.70 billion. Avantor had a trailing twelve-month return on equity of 14.11% and a net margin of 4.61%. Avantor's quarterly revenue was down 4.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.32 earnings per share.

What guidance has Avantor issued on next quarter's earnings?

Avantor updated its FY 2024 earnings guidance on Wednesday, February, 14th. The company provided EPS guidance of 0.960-1.040 for the period, compared to the consensus EPS estimate of 1.060. The company issued revenue guidance of -.

What other stocks do shareholders of Avantor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), RTX (RTX), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Pfizer (PFE) and QUALCOMM (QCOM).

When did Avantor IPO?

Avantor (AVTR) raised $3 billion in an initial public offering on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies acted as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Who are Avantor's major shareholders?

Avantor's stock is owned by many different retail and institutional investors. Top institutional shareholders include Artemis Investment Management LLP (1.34%), Sumitomo Mitsui Trust Holdings Inc. (0.24%), Perpetual Ltd (0.19%), Vaughan Nelson Investment Management L.P. (0.18%), Dudley & Shanley Inc. (0.16%) and Allspring Global Investments Holdings LLC (0.13%). Insiders that own company stock include Christophe Couturier, David D Petratis, Devashish Ohri, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Jo Natauri, Justin Miller, Michael Stubblefield, Rajiv Gupta, Steven W Eck and Thomas A Szlosek.
View institutional ownership trends
.

How do I buy shares of Avantor?

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:AVTR) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners